BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12408443)

  • 1. Use of Lactobacillus-GG in paediatric Crohn's disease.
    Guandalini S
    Dig Liver Dis; 2002 Sep; 34 Suppl 2():S63-5. PubMed ID: 12408443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study.
    Gupta P; Andrew H; Kirschner BS; Guandalini S
    J Pediatr Gastroenterol Nutr; 2000 Oct; 31(4):453-7. PubMed ID: 11045848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactobacillus GG in inducing and maintaining remission of Crohn's disease.
    Schultz M; Timmer A; Herfarth HH; Sartor RB; Vanderhoof JA; Rath HC
    BMC Gastroenterol; 2004 Mar; 4():5. PubMed ID: 15113451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease.
    Bousvaros A; Guandalini S; Baldassano RN; Botelho C; Evans J; Ferry GD; Goldin B; Hartigan L; Kugathasan S; Levy J; Murray KF; Oliva-Hemker M; Rosh JR; Tolia V; Zholudev A; Vanderhoof JA; Hibberd PL
    Inflamm Bowel Dis; 2005 Sep; 11(9):833-9. PubMed ID: 16116318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.
    Prantera C; Scribano ML; Falasco G; Andreoli A; Luzi C
    Gut; 2002 Sep; 51(3):405-9. PubMed ID: 12171964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics and Crohn's disease.
    Prantera C; Scribano ML
    Dig Liver Dis; 2002 Sep; 34 Suppl 2():S66-7. PubMed ID: 12408444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics for maintenance of remission in Crohn's disease.
    Rolfe VE; Fortun PJ; Hawkey CJ; Bath-Hextall F
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004826. PubMed ID: 17054217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG.
    Malin M; Suomalainen H; Saxelin M; Isolauri E
    Ann Nutr Metab; 1996; 40(3):137-45. PubMed ID: 8862696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection.
    Van Gossum A; Dewit O; Louis E; de Hertogh G; Baert F; Fontaine F; DeVos M; Enslen M; Paintin M; Franchimont D
    Inflamm Bowel Dis; 2007 Feb; 13(2):135-42. PubMed ID: 17206696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review.
    Ganji-Arjenaki M; Rafieian-Kopaei M
    J Cell Physiol; 2018 Mar; 233(3):2091-2103. PubMed ID: 28294322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease.
    Fedorak RN; Feagan BG; Hotte N; Leddin D; Dieleman LA; Petrunia DM; Enns R; Bitton A; Chiba N; Paré P; Rostom A; Marshall J; Depew W; Bernstein CN; Panaccione R; Aumais G; Steinhart AH; Cockeram A; Bailey RJ; Gionchetti P; Wong C; Madsen K
    Clin Gastroenterol Hepatol; 2015 May; 13(5):928-35.e2. PubMed ID: 25460016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics and prebiotics in Crohn's disease therapies.
    Lichtenstein L; Avni-Biron I; Ben-Bassat O
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):81-8. PubMed ID: 27048899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.
    Marteau P; Lémann M; Seksik P; Laharie D; Colombel JF; Bouhnik Y; Cadiot G; Soulé JC; Bourreille A; Metman E; Lerebours E; Carbonnel F; Dupas JL; Veyrac M; Coffin B; Moreau J; Abitbol V; Blum-Sperisen S; Mary JY
    Gut; 2006 Jun; 55(6):842-7. PubMed ID: 16377775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?
    Malchow HA
    J Clin Gastroenterol; 1997 Dec; 25(4):653-8. PubMed ID: 9451682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics for prevention and treatment of diarrhea.
    Guandalini S
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S149-53. PubMed ID: 21992955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D; Macdonald JK; Chande N
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn's disease.
    Steed H; Macfarlane GT; Blackett KL; Bahrami B; Reynolds N; Walsh SV; Cummings JH; Macfarlane S
    Aliment Pharmacol Ther; 2010 Oct; 32(7):872-83. PubMed ID: 20735782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial.
    Bauserman M; Michail S
    J Pediatr; 2005 Aug; 147(2):197-201. PubMed ID: 16126049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics and the management of inflammatory bowel disease.
    Fedorak RN; Madsen KL
    Inflamm Bowel Dis; 2004 May; 10(3):286-99. PubMed ID: 15290926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of probiotics in inflammatory bowel disease.
    Cain AM; Karpa KD
    Altern Ther Health Med; 2011; 17(1):72-9. PubMed ID: 21614946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.